On December 16, investment 1The 500 million yuan Ningxia Aier Eye Hospital General Hospital was officially opened, which is the fourth specialized eye hospital built by Aier Ophthalmology in Ningxia. At the launching ceremony, Ningxia's first eye health science museum was also opened in the General Hospital of Ningxia Aier Eye Hospital.
It is understood that the new hospital of Ningxia Aier Eye Hospital covers an area of nearly 20,000 square meters, with 100 beds, 50 outpatient clinics and optometry rooms, and 13 ophthalmic operating rooms. The hospital has built a corneal transplant surgery consultation center, a consultation center for difficult corneal ocular surface diseases, a chronic disease management center for diabetic retinopathy, a prevention and control base for adolescent myopia, and a center for optimizing difficult cataract surgery programs.
The Ningxia Eye Health Science Museum, which opened at the same time, is the first exhibition hall in Ningxia with the theme of eye health science popularization, covering an area of more than 500 square meters.
Not long ago, that is, on November 30, Aier Ophthalmology just announced the acquisition of Tangshan Aier and other 7 hospital controlling stakes for nearly 300 million yuan, and after nearly a month, the news of the opening of the new hospital came, this series of dynamics shows that the company's expansion in the field of ophthalmic medical care is still continuing.
Founded in 2003, Aier Ophthalmology has developed into the world's largest ophthalmic medical institution, with 3 listed companies in Chinese mainland, Europe and Southeast Asia, and 816 brand hospitals, ophthalmology centers and clinics worldwide as of 2022. As of the end of June 2023, Aier Ophthalmology has 229 hospitals and 168 outpatient departments in China, an increase of 14 hospitals and 20 outpatient departments from half a year ago.
At this year's shareholders' meeting, Chen Bang, the founder of Aier Ophthalmology, also talked about the company's grand goal of "building 1,000 optometry clinics" in the field of "optometry" in the future. Chen Bang said that in recent years, Aier Ophthalmology has been exploring the optometry clinic model that is in line with the company's development, and hopes to develop 1,000 optometry clinics in the first phase through the technical support of hospitals in the same city in the future, and continue to adjust and improve according to the development situation, and continue to deepen the company's "strong grassroots" plan.
In recent years, the scale of the domestic ophthalmic medical market has grown steadily. If it can be maintained 2016-2020 17With a compound annual growth rate of 3%, it is expected that by 2024, the market size of China's ophthalmic medical services will reach 2563100 million yuan.
At present, there are 8 listed companies in China, including Aier Ophthalmology, Huaxia Ophthalmology, Guangzheng Ophthalmology, etc., and the domestic ophthalmic medical market has presented a competitive pattern of "one super and many strong".
However, the uneven distribution of ophthalmic medical resources in China has been an industry consensus. According to relevant statistics, at this stage, 70% of the country's ophthalmologists are distributed in large and medium-sized cities, and the distribution of ophthalmic medical institutions also presents the characteristics of "strong provincial capitals and weak grassroots", and the grassroots also have a huge demand for ophthalmic diagnosis and treatment.
The sinking market has become a market that ophthalmic medical service giants have targeted in recent years.
Article**: Huaxia Medical Network (sharing medical management strategies, serving hospital trading).